FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032140498> ?p ?o ?g. }

• W2032140498 endingPage "624" @default.
• W2032140498 startingPage "614" @default.
• W2032140498 abstract "To evaluate the efficacy and safety of anakinra in combination with methotrexate (MTX) in patients with active rheumatoid arthritis (RA).Patients with moderate-to-severe active RA who were receiving MTX for 6 consecutive months, with stable doses for > or = 3 months (those with disease duration of >6 months but <12 years) were randomized into 6 groups: placebo or 0.04, 0.1, 0.4, 1.0, or 2.0 mg/kg of anakinra administered in a single, daily, subcutaneous injection. The primary efficacy end point was the proportion of subjects who met the American College of Rheumatology 20% improvement criteria (attained an ACR20 response) at week 12.A total of 419 patients were randomized in the study. Patient demographics and disease status were similar in the 6 treatment groups. The ACR20 responses at week 12 in the 5 active treatment plus MTX groups demonstrated a statistically significant (P = 0.001) dose-response relationship compared with the ACR20 response in the placebo plus MTX group. The ACR20 response rate in the anakinra 1.0-mg/kg (46%; P = 0.001) and 2.0-mg/kg (38%; P = 0.007) dose groups was significantly greater than that in the placebo group (19%). The ACR20 responses at 24 weeks were consistent with those at 12 weeks. Similar improvements in anakinra-treated subjects were noted in individual ACR components, erythrocyte sedimentation rate, onset of ACR20 response, sustainability of ACR20 response, and magnitude of ACR response. Anakinra was safe and well tolerated. Injection site reaction was the most frequently noted adverse event, and this led to premature study withdrawal in 7% (1.0-mg/kg group) to 10% (2.0-mg/kg group) of patients receiving higher doses.In patients with persistently active RA, the combination of anakinra and MTX was safe and well tolerated and provided significantly greater clinical benefit than MTX alone." @default.
• W2032140498 created "2016-06-24" @default.
• W2032140498 creator A5014147030 @default.
• W2032140498 creator A5027653429 @default.
• W2032140498 creator A5047117557 @default.
• W2032140498 creator A5047233668 @default.
• W2032140498 creator A5057538503 @default.
• W2032140498 creator A5064312036 @default.
• W2032140498 creator A5065309148 @default.
• W2032140498 creator A5065536093 @default.
• W2032140498 creator A5066780563 @default.
• W2032140498 creator A5068487815 @default.
• W2032140498 date "2002-03-01" @default.
• W2032140498 modified "2023-09-30" @default.
• W2032140498 title "Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial" @default.
• W2032140498 cites W1520223434 @default.
• W2032140498 cites W1558053349 @default.
• W2032140498 cites W1958984156 @default.
• W2032140498 cites W1978103379 @default.
• W2032140498 cites W1983331471 @default.
• W2032140498 cites W1985004174 @default.
• W2032140498 cites W1985763670 @default.
• W2032140498 cites W1990347684 @default.
• W2032140498 cites W1996472975 @default.
• W2032140498 cites W1998253405 @default.
• W2032140498 cites W2011437322 @default.
• W2032140498 cites W2014401459 @default.
• W2032140498 cites W2023174251 @default.
• W2032140498 cites W2026080578 @default.
• W2032140498 cites W2035274613 @default.
• W2032140498 cites W2043100866 @default.
• W2032140498 cites W2050390987 @default.
• W2032140498 cites W2055493846 @default.
• W2032140498 cites W2060408250 @default.
• W2032140498 cites W2078835830 @default.
• W2032140498 cites W2081734937 @default.
• W2032140498 cites W2087028773 @default.
• W2032140498 cites W2097564087 @default.
• W2032140498 cites W2098015378 @default.
• W2032140498 cites W2111540856 @default.
• W2032140498 cites W2115871198 @default.
• W2032140498 cites W2118347756 @default.
• W2032140498 cites W2120574509 @default.
• W2032140498 cites W2131817768 @default.
• W2032140498 cites W2152348310 @default.
• W2032140498 cites W2159106700 @default.
• W2032140498 cites W2257569374 @default.
• W2032140498 cites W2314052274 @default.
• W2032140498 cites W2328587823 @default.
• W2032140498 cites W2332178455 @default.
• W2032140498 cites W3022421938 @default.
• W2032140498 doi "https://doi.org/10.1002/art.10141" @default.
• W2032140498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11920396" @default.
• W2032140498 hasPublicationYear "2002" @default.
• W2032140498 type Work @default.
• W2032140498 sameAs 2032140498 @default.
• W2032140498 citedByCount "581" @default.
• W2032140498 countsByYear W20321404982012 @default.
• W2032140498 countsByYear W20321404982013 @default.
• W2032140498 countsByYear W20321404982014 @default.
• W2032140498 countsByYear W20321404982015 @default.
• W2032140498 countsByYear W20321404982016 @default.
• W2032140498 countsByYear W20321404982017 @default.
• W2032140498 countsByYear W20321404982018 @default.
• W2032140498 countsByYear W20321404982019 @default.
• W2032140498 countsByYear W20321404982020 @default.
• W2032140498 countsByYear W20321404982021 @default.
• W2032140498 countsByYear W20321404982022 @default.
• W2032140498 countsByYear W20321404982023 @default.
• W2032140498 crossrefType "journal-article" @default.
• W2032140498 hasAuthorship W2032140498A5014147030 @default.
• W2032140498 hasAuthorship W2032140498A5027653429 @default.
• W2032140498 hasAuthorship W2032140498A5047117557 @default.
• W2032140498 hasAuthorship W2032140498A5047233668 @default.
• W2032140498 hasAuthorship W2032140498A5057538503 @default.
• W2032140498 hasAuthorship W2032140498A5064312036 @default.
• W2032140498 hasAuthorship W2032140498A5065309148 @default.
• W2032140498 hasAuthorship W2032140498A5065536093 @default.
• W2032140498 hasAuthorship W2032140498A5066780563 @default.
• W2032140498 hasAuthorship W2032140498A5068487815 @default.
• W2032140498 hasConcept C126322002 @default.
• W2032140498 hasConcept C141071460 @default.
• W2032140498 hasConcept C142724271 @default.
• W2032140498 hasConcept C168563851 @default.
• W2032140498 hasConcept C198451711 @default.
• W2032140498 hasConcept C202061045 @default.
• W2032140498 hasConcept C204787440 @default.
• W2032140498 hasConcept C27081682 @default.
• W2032140498 hasConcept C2777077863 @default.
• W2032140498 hasConcept C2777575956 @default.
• W2032140498 hasConcept C2778143017 @default.
• W2032140498 hasConcept C2779134260 @default.
• W2032140498 hasConcept C2781059491 @default.
• W2032140498 hasConcept C2781228260 @default.
• W2032140498 hasConcept C2991744798 @default.
• W2032140498 hasConcept C71924100 @default.
• W2032140498 hasConcept C90924648 @default.
• W2032140498 hasConceptScore W2032140498C126322002 @default.

• next